Myelodysplastic Syndrome Patient-derived Xenografts: from No Options to Many

Overview

Journal Haematologica

Specialty Hematology

Date 2020 Mar 21

PMID 32193253

Citations 13

Authors

Christophe Come

Alexander Balhuizen

Dominique Bonnet

Bo T Porse

Affiliations

Soon will be listed here.

Citing Articles

Research and analysis of differential gene expression in CD34 hematopoietic stem cells in myelodysplastic syndromes.

Wang M, Liao C, Wei X, Xie Y, Han P, Yu Y PLoS One. 2025; 20(3):e0315408.

PMID: 40073065 PMC: 11902259. DOI: 10.1371/journal.pone.0315408.

Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment.

Ren K, Li E, Aydemir I, Liu Y, Han X, Bi H Blood Adv. 2024; 9(1):54-65.

PMID: 39471483 PMC: 11732577. DOI: 10.1182/bloodadvances.2024013361.

Malignant progression of preleukemic disorders.

Hall T, Gurbuxani S, Crispino J Blood. 2024; 143(22):2245-2255.

PMID: 38498034 PMC: 11181356. DOI: 10.1182/blood.2023020817.

Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy.

Lang Y, Lyu Y, Tan Y, Hu Z Front Immunol. 2023; 14:1195194.

PMID: 37646021 PMC: 10461088. DOI: 10.3389/fimmu.2023.1195194.

[Mechanisms by which the bone marrow microenvironment of myelodysplastic neoplasms contributes to disease progression].

Hong M, Chang C Zhonghua Xue Ye Xue Za Zhi. 2023; 44(4):350-352.

PMID: 37357010 PMC: 10282869. DOI: 10.3760/cma.j.issn.0253-2727.2023.04.018.

References

Wang J, Li Z, He Y, Pan F, Chen S, Rhodes S . Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice. Blood. 2013; 123(4):541-53. PMC: 3901067. DOI: 10.1182/blood-2013-05-500272. View

Meunier M, Dussiau C, Mauz N, Alary A, Lefebvre C, Szymanski G . Molecular dissection of engraftment in a xenograft model of myelodysplastic syndromes. Oncotarget. 2018; 9(19):14993-15000. PMC: 5871091. DOI: 10.18632/oncotarget.24538. View

Herndler-Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M . Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc Natl Acad Sci U S A. 2017; 114(45):E9626-E9634. PMC: 5692533. DOI: 10.1073/pnas.1705301114. View

Abarrategi A, Foster K, Hamilton A, Mian S, Passaro D, Gribben J . Versatile humanized niche model enables study of normal and malignant human hematopoiesis. J Clin Invest. 2017; 127(2):543-548. PMC: 5272182. DOI: 10.1172/JCI89364. View

Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C . Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 2011; 20(1):11-24. PMC: 3194039. DOI: 10.1016/j.ccr.2011.06.001. View

Poon Z, Dighe N, Venkatesan S, Cheung A, Fan X, Bari S . Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy. Leukemia. 2018; 33(6):1487-1500. PMC: 6756222. DOI: 10.1038/s41375-018-0310-y. View

Reinisch A, Cruz Hernandez D, Schallmoser K, Majeti R . Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into mice. Nat Protoc. 2017; 12(10):2169-2188. PMC: 5898606. DOI: 10.1038/nprot.2017.088. View

Teofili L, Martini M, Nuzzolo E, Capodimonti S, Iachininoto M, Cocomazzi A . Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia. Neoplasia. 2015; 17(5):401-9. PMC: 4468365. DOI: 10.1016/j.neo.2015.04.001. View

Stevens B, Khan N, DAlessandro A, Nemkov T, Winters A, Jones C . Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes. Nat Commun. 2018; 9(1):3694. PMC: 6135858. DOI: 10.1038/s41467-018-05984-x. View

10.

Chen Y, Jacamo R, Shi Y, Wang R, Battula V, Konoplev S . Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment. Blood. 2012; 119(21):4971-80. PMC: 3367899. DOI: 10.1182/blood-2011-11-389957. View

11.

Obeng E, Chappell R, Seiler M, Chen M, Campagna D, Schmidt P . Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation. Cancer Cell. 2016; 30(3):404-417. PMC: 5023069. DOI: 10.1016/j.ccell.2016.08.006. View

12.

Wunderlich M, Chou F, Link K, Mizukawa B, Perry R, Carroll M . AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia. 2010; 24(10):1785-8. PMC: 5439963. DOI: 10.1038/leu.2010.158. View

13.

Shastri A, Choudhary G, Teixeira M, Gordon-Mitchell S, Ramachandra N, Bernard L . Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells. J Clin Invest. 2018; 128(12):5479-5488. PMC: 6264739. DOI: 10.1172/JCI120156. View

14.

Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty S, Teichmann L . Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol. 2014; 32(4):364-72. PMC: 4017589. DOI: 10.1038/nbt.2858. View

15.

Krevvata M, Shan X, Zhou C, Dos Santos C, Habineza Ndikuyeze G, Secreto A . Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells. Haematologica. 2018; 103(6):959-971. PMC: 6058784. DOI: 10.3324/haematol.2017.183202. View

16.

Franks C, Bishop D, Balkwill F, Oliver R, SPECTOR W . Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice. Br J Cancer. 1977; 35(5):697-700. PMC: 2025502. DOI: 10.1038/bjc.1977.107. View

17.

Kim E, Ilagan J, Liang Y, Daubner G, Lee S, Ramakrishnan A . SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition. Cancer Cell. 2015; 27(5):617-30. PMC: 4429920. DOI: 10.1016/j.ccell.2015.04.006. View

18.

Medyouf H, Mossner M, Jann J, Nolte F, Raffel S, Herrmann C . Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 2014; 14(6):824-37. DOI: 10.1016/j.stem.2014.02.014. View

19.

Smith M, Choudhary G, Pellagatti A, Choi K, Bolanos L, Bhagat T . U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies. Nat Cell Biol. 2019; 21(5):640-650. PMC: 6679973. DOI: 10.1038/s41556-019-0314-5. View

20.

Beachy S, Aplan P . Mouse models of myelodysplastic syndromes. Hematol Oncol Clin North Am. 2010; 24(2):361-75. PMC: 2848962. DOI: 10.1016/j.hoc.2010.02.002. View